Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nirit Mor-Vaknin

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Blood Cells, Molecules & Diseases|August 17, 2014
DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML)Gemma E Logan, Nirit Mor-Vaknin, Till Braunschweig, et al.
Arthritis and Rheumatism|February 1, 2011
DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigenNirit Mor-Vaknin, Ferdinand Kappes, Amalie E Dick, et al.
Frontiers in Immunology|January 31, 2020
Citrullinated Histone H3 as a Therapeutic Target for Endotoxic Shock in MiceQiufang Deng, Baihong Pan, Hasan B Alam, et al.
Plos One|September 23, 2016
Vimentin, a Novel NF-κB Regulator, Is Required for Meningitic Escherichia coli K1-Induced Pathogen Invasion and PMN Transmigration across the Blood-Brain BarrierSheng-He Huang, Feng Chi, Liang Peng, et al.
Molecular and Cellular Biology|October 13, 2006
The DEK nuclear autoantigen is a secreted chemotactic factorNirit Mor-Vaknin, Antonello Punturieri, Kajal Sitwala, et al.
Chemistry & Biology|June 23, 2007
The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentinPaola Bargagna-Mohan, Adel Hamza, Yang-eon Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Intercellular trafficking of the nuclear oncoprotein DEKAnjan K Saha, Ferdinand Kappes, Amruta Mundade, et al.
The Journal of Clinical Investigation|May 21, 2019
Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signalingMaegan L Capitano, Nirit Mor-Vaknin, Anjan K Saha, et al.
Lupus|March 29, 2020
Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritisAndrew J Kinloch, Matthew D Cascino, Jian Dai, et al.
Nature Microbiology|August 31, 2016
Intermediate filaments enable pathogen docking to trigger type 3 effector translocationBrian C Russo, Luisa M Stamm, Matthijs Raaben, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Blood Cells, Molecules & Diseases|August 17, 2014
DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML)Gemma E Logan, Nirit Mor-Vaknin, Till Braunschweig, et al.
Arthritis and Rheumatism|February 1, 2011
DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigenNirit Mor-Vaknin, Ferdinand Kappes, Amalie E Dick, et al.
Frontiers in Immunology|January 31, 2020
Citrullinated Histone H3 as a Therapeutic Target for Endotoxic Shock in MiceQiufang Deng, Baihong Pan, Hasan B Alam, et al.
Plos One|September 23, 2016
Vimentin, a Novel NF-κB Regulator, Is Required for Meningitic Escherichia coli K1-Induced Pathogen Invasion and PMN Transmigration across the Blood-Brain BarrierSheng-He Huang, Feng Chi, Liang Peng, et al.
Molecular and Cellular Biology|October 13, 2006
The DEK nuclear autoantigen is a secreted chemotactic factorNirit Mor-Vaknin, Antonello Punturieri, Kajal Sitwala, et al.
Chemistry & Biology|June 23, 2007
The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentinPaola Bargagna-Mohan, Adel Hamza, Yang-eon Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Intercellular trafficking of the nuclear oncoprotein DEKAnjan K Saha, Ferdinand Kappes, Amruta Mundade, et al.
The Journal of Clinical Investigation|May 21, 2019
Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signalingMaegan L Capitano, Nirit Mor-Vaknin, Anjan K Saha, et al.
Lupus|March 29, 2020
Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritisAndrew J Kinloch, Matthew D Cascino, Jian Dai, et al.
Nature Microbiology|August 31, 2016
Intermediate filaments enable pathogen docking to trigger type 3 effector translocationBrian C Russo, Luisa M Stamm, Matthijs Raaben, et al.
Pageof 3